What is the current valuation of the Pharmaceutical Granulation Equipment Market?

As of 2024, the market valuation was 5.67 USD Billion. Read More

What is the projected market size for the Pharmaceutical Granulation Equipment Market by 2035?

The market is expected to reach 8.19 USD Billion by 2035. Read More

What is the expected CAGR for the Pharmaceutical Granulation Equipment Market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 3.4%. Read More

Which equipment types are leading in the Pharmaceutical Granulation Equipment Market?

High Shear Granulators and Fluid Bed Granulators are among the leading equipment types, with valuations of 2.4 and 1.7 USD Billion respectively by 2035. Read More

How does the market segment by formulation type appear in terms of valuation?

By 2035, Solid Dosage is projected to reach 4.0 USD Billion, indicating its dominance in the formulation type segment. Read More

What are the key end-use segments in the Pharmaceutical Granulation Equipment Market?

Pharmaceutical Manufacturers lead the end-use segment, with a projected valuation of 4.8 USD Billion by 2035. Read More

What scale of operation is expected to dominate the market?

The Industrial Scale is anticipated to dominate, with a projected valuation of 5.29 USD Billion by 2035. Read More

Who are the key players in the Pharmaceutical Granulation Equipment Market?

Key players include GEA Group AG, Fette Compacting GmbH, and Bosch Packaging Technology, among others. Read More

What is the projected growth for Roller Compactors in the market?

Roller Compactors are expected to grow to 1.4 USD Billion by 2035. Read More

How does the market for Contract Manufacturing Organizations appear in terms of growth?

The market for Contract Manufacturing Organizations is projected to reach 2.4 USD Billion by 2035, indicating substantial growth. Read More

Pharmaceutical Granulation Equipment Market

ID: MRFR/MED/41605-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Pharmaceutical Granulation Equipment Market Research Report By Equipment Type (High Shear Granulator, Fluid Bed Granulator, Roller Compactor, Granulation and Coating Equipment), By Formulation Type (Solid Dosage, Liquid Dosage, Semi-Solid Dosage), By End Use (Pharmaceutical Manufacturers, Contract Manufacturing Organizations, Research Institutions), By Scale of Operation (Laboratory Scale, Pilot Scale, Industrial Scale) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Pharmaceutical Granulation Equipment Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Healthcare, BY Equipment Type (USD Billion)
4.1.1 High Shear Granulator
4.1.2 Fluid Bed Granulator
4.1.3 Roller Compactor
4.1.4 Granulation and Coating Equipment
4.2 Healthcare, BY Formulation Type (USD Billion)
4.2.1 Solid Dosage
4.2.2 Liquid Dosage
4.2.3 Semi-Solid Dosage
4.3 Healthcare, BY End Use (USD Billion)
4.3.1 Pharmaceutical Manufacturers
4.3.2 Contract Manufacturing Organizations
4.3.3 Research Institutions
4.4 Healthcare, BY Scale of Operation (USD Billion)
4.4.1 Laboratory Scale
4.4.2 Pilot Scale
4.4.3 Industrial Scale
4.5 Healthcare, BY Region (USD Billion)
4.5.1 North America
4.5.1.1 US
4.5.1.2 Canada
4.5.2 Europe
4.5.2.1 Germany
4.5.2.2 UK
4.5.2.3 France
4.5.2.4 Russia
4.5.2.5 Italy
4.5.2.6 Spain
4.5.2.7 Rest of Europe
4.5.3 APAC
4.5.3.1 China
4.5.3.2 India
4.5.3.3 Japan
4.5.3.4 South Korea
4.5.3.5 Malaysia
4.5.3.6 Thailand
4.5.3.7 Indonesia
4.5.3.8 Rest of APAC
4.5.4 South America
4.5.4.1 Brazil
4.5.4.2 Mexico
4.5.4.3 Argentina
4.5.4.4 Rest of South America
4.5.5 MEA
4.5.5.1 GCC Countries
4.5.5.2 South Africa
4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Healthcare
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 GEA Group AG (DE)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Fette Compacting GmbH (DE)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Bosch Packaging Technology (DE)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Schneider Electric (FR)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Korsch AG (DE)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Romaco Pharmatechnik GmbH (DE)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 L.B. Bohle Maschinen + Verfahren GmbH (DE)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Coperion GmbH (DE)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY EQUIPMENT TYPE
6.4 US MARKET ANALYSIS BY FORMULATION TYPE
6.5 US MARKET ANALYSIS BY END USE
6.6 US MARKET ANALYSIS BY SCALE OF OPERATION
6.7 CANADA MARKET ANALYSIS BY EQUIPMENT TYPE
6.8 CANADA MARKET ANALYSIS BY FORMULATION TYPE
6.9 CANADA MARKET ANALYSIS BY END USE
6.10 CANADA MARKET ANALYSIS BY SCALE OF OPERATION
6.11 EUROPE MARKET ANALYSIS
6.12 GERMANY MARKET ANALYSIS BY EQUIPMENT TYPE
6.13 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
6.14 GERMANY MARKET ANALYSIS BY END USE
6.15 GERMANY MARKET ANALYSIS BY SCALE OF OPERATION
6.16 UK MARKET ANALYSIS BY EQUIPMENT TYPE
6.17 UK MARKET ANALYSIS BY FORMULATION TYPE
6.18 UK MARKET ANALYSIS BY END USE
6.19 UK MARKET ANALYSIS BY SCALE OF OPERATION
6.20 FRANCE MARKET ANALYSIS BY EQUIPMENT TYPE
6.21 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
6.22 FRANCE MARKET ANALYSIS BY END USE
6.23 FRANCE MARKET ANALYSIS BY SCALE OF OPERATION
6.24 RUSSIA MARKET ANALYSIS BY EQUIPMENT TYPE
6.25 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE
6.26 RUSSIA MARKET ANALYSIS BY END USE
6.27 RUSSIA MARKET ANALYSIS BY SCALE OF OPERATION
6.28 ITALY MARKET ANALYSIS BY EQUIPMENT TYPE
6.29 ITALY MARKET ANALYSIS BY FORMULATION TYPE
6.30 ITALY MARKET ANALYSIS BY END USE
6.31 ITALY MARKET ANALYSIS BY SCALE OF OPERATION
6.32 SPAIN MARKET ANALYSIS BY EQUIPMENT TYPE
6.33 SPAIN MARKET ANALYSIS BY FORMULATION TYPE
6.34 SPAIN MARKET ANALYSIS BY END USE
6.35 SPAIN MARKET ANALYSIS BY SCALE OF OPERATION
6.36 REST OF EUROPE MARKET ANALYSIS BY EQUIPMENT TYPE
6.37 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE
6.38 REST OF EUROPE MARKET ANALYSIS BY END USE
6.39 REST OF EUROPE MARKET ANALYSIS BY SCALE OF OPERATION
6.40 APAC MARKET ANALYSIS
6.41 CHINA MARKET ANALYSIS BY EQUIPMENT TYPE
6.42 CHINA MARKET ANALYSIS BY FORMULATION TYPE
6.43 CHINA MARKET ANALYSIS BY END USE
6.44 CHINA MARKET ANALYSIS BY SCALE OF OPERATION
6.45 INDIA MARKET ANALYSIS BY EQUIPMENT TYPE
6.46 INDIA MARKET ANALYSIS BY FORMULATION TYPE
6.47 INDIA MARKET ANALYSIS BY END USE
6.48 INDIA MARKET ANALYSIS BY SCALE OF OPERATION
6.49 JAPAN MARKET ANALYSIS BY EQUIPMENT TYPE
6.50 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
6.51 JAPAN MARKET ANALYSIS BY END USE
6.52 JAPAN MARKET ANALYSIS BY SCALE OF OPERATION
6.53 SOUTH KOREA MARKET ANALYSIS BY EQUIPMENT TYPE
6.54 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE
6.55 SOUTH KOREA MARKET ANALYSIS BY END USE
6.56 SOUTH KOREA MARKET ANALYSIS BY SCALE OF OPERATION
6.57 MALAYSIA MARKET ANALYSIS BY EQUIPMENT TYPE
6.58 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE
6.59 MALAYSIA MARKET ANALYSIS BY END USE
6.60 MALAYSIA MARKET ANALYSIS BY SCALE OF OPERATION
6.61 THAILAND MARKET ANALYSIS BY EQUIPMENT TYPE
6.62 THAILAND MARKET ANALYSIS BY FORMULATION TYPE
6.63 THAILAND MARKET ANALYSIS BY END USE
6.64 THAILAND MARKET ANALYSIS BY SCALE OF OPERATION
6.65 INDONESIA MARKET ANALYSIS BY EQUIPMENT TYPE
6.66 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE
6.67 INDONESIA MARKET ANALYSIS BY END USE
6.68 INDONESIA MARKET ANALYSIS BY SCALE OF OPERATION
6.69 REST OF APAC MARKET ANALYSIS BY EQUIPMENT TYPE
6.70 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE
6.71 REST OF APAC MARKET ANALYSIS BY END USE
6.72 REST OF APAC MARKET ANALYSIS BY SCALE OF OPERATION
6.73 SOUTH AMERICA MARKET ANALYSIS
6.74 BRAZIL MARKET ANALYSIS BY EQUIPMENT TYPE
6.75 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE
6.76 BRAZIL MARKET ANALYSIS BY END USE
6.77 BRAZIL MARKET ANALYSIS BY SCALE OF OPERATION
6.78 MEXICO MARKET ANALYSIS BY EQUIPMENT TYPE
6.79 MEXICO MARKET ANALYSIS BY FORMULATION TYPE
6.80 MEXICO MARKET ANALYSIS BY END USE
6.81 MEXICO MARKET ANALYSIS BY SCALE OF OPERATION
6.82 ARGENTINA MARKET ANALYSIS BY EQUIPMENT TYPE
6.83 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE
6.84 ARGENTINA MARKET ANALYSIS BY END USE
6.85 ARGENTINA MARKET ANALYSIS BY SCALE OF OPERATION
6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY EQUIPMENT TYPE
6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE
6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY SCALE OF OPERATION
6.90 MEA MARKET ANALYSIS
6.91 GCC COUNTRIES MARKET ANALYSIS BY EQUIPMENT TYPE
6.92 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE
6.93 GCC COUNTRIES MARKET ANALYSIS BY END USE
6.94 GCC COUNTRIES MARKET ANALYSIS BY SCALE OF OPERATION
6.95 SOUTH AFRICA MARKET ANALYSIS BY EQUIPMENT TYPE
6.96 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE
6.97 SOUTH AFRICA MARKET ANALYSIS BY END USE
6.98 SOUTH AFRICA MARKET ANALYSIS BY SCALE OF OPERATION
6.99 REST OF MEA MARKET ANALYSIS BY EQUIPMENT TYPE
6.100 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE
6.101 REST OF MEA MARKET ANALYSIS BY END USE
6.102 REST OF MEA MARKET ANALYSIS BY SCALE OF OPERATION
6.103 KEY BUYING CRITERIA OF HEALTHCARE
6.104 RESEARCH PROCESS OF MRFR
6.105 DRO ANALYSIS OF HEALTHCARE
6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
6.109 HEALTHCARE, BY EQUIPMENT TYPE, 2024 (% SHARE)
6.110 HEALTHCARE, BY EQUIPMENT TYPE, 2024 TO 2035 (USD Billion)
6.111 HEALTHCARE, BY FORMULATION TYPE, 2024 (% SHARE)
6.112 HEALTHCARE, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
6.113 HEALTHCARE, BY END USE, 2024 (% SHARE)
6.114 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
6.115 HEALTHCARE, BY SCALE OF OPERATION, 2024 (% SHARE)
6.116 HEALTHCARE, BY SCALE OF OPERATION, 2024 TO 2035 (USD Billion)
6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.2.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.2.3 BY END USE, 2025-2035 (USD Billion)
7.2.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.3.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.3.3 BY END USE, 2025-2035 (USD Billion)
7.3.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.4.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.4.3 BY END USE, 2025-2035 (USD Billion)
7.4.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.5.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.5.3 BY END USE, 2025-2035 (USD Billion)
7.5.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.6.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.6.3 BY END USE, 2025-2035 (USD Billion)
7.6.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.7.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.7.3 BY END USE, 2025-2035 (USD Billion)
7.7.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.8.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.8.3 BY END USE, 2025-2035 (USD Billion)
7.8.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.9.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.9.3 BY END USE, 2025-2035 (USD Billion)
7.9.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.10.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.10.3 BY END USE, 2025-2035 (USD Billion)
7.10.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.11.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.11.3 BY END USE, 2025-2035 (USD Billion)
7.11.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.12.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.12.3 BY END USE, 2025-2035 (USD Billion)
7.12.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.13.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.13.3 BY END USE, 2025-2035 (USD Billion)
7.13.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.14.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.14.3 BY END USE, 2025-2035 (USD Billion)
7.14.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.15.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.15.3 BY END USE, 2025-2035 (USD Billion)
7.15.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.16.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.16.3 BY END USE, 2025-2035 (USD Billion)
7.16.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.17.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.17.3 BY END USE, 2025-2035 (USD Billion)
7.17.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.18.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.18.3 BY END USE, 2025-2035 (USD Billion)
7.18.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.19.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.19.3 BY END USE, 2025-2035 (USD Billion)
7.19.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.20.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.20.3 BY END USE, 2025-2035 (USD Billion)
7.20.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.21.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.21.3 BY END USE, 2025-2035 (USD Billion)
7.21.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.22.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.22.3 BY END USE, 2025-2035 (USD Billion)
7.22.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.23.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.23.3 BY END USE, 2025-2035 (USD Billion)
7.23.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.24.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.24.3 BY END USE, 2025-2035 (USD Billion)
7.24.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.25.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.25.3 BY END USE, 2025-2035 (USD Billion)
7.25.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.26.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.26.3 BY END USE, 2025-2035 (USD Billion)
7.26.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.27.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.27.3 BY END USE, 2025-2035 (USD Billion)
7.27.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.28.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.28.3 BY END USE, 2025-2035 (USD Billion)
7.28.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.29.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.29.3 BY END USE, 2025-2035 (USD Billion)
7.29.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.30.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.30.3 BY END USE, 2025-2035 (USD Billion)
7.30.4 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Equipment Type (USD Billion, 2025-2035)

High Shear Granulator
Fluid Bed Granulator
Roller Compactor
Granulation and Coating Equipment

Healthcare By Formulation Type (USD Billion, 2025-2035)

Solid Dosage
Liquid Dosage
Semi-Solid Dosage

Healthcare By End Use (USD Billion, 2025-2035)

Pharmaceutical Manufacturers
Contract Manufacturing Organizations
Research Institutions

Healthcare By Scale of Operation (USD Billion, 2025-2035)

Laboratory Scale
Pilot Scale
Industrial Scale

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓